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ABSTRACT
Achalasia is a rare motor disorder of the esophagus and lower esophageal sphincter. The incidence is 
approximately 1/100,000 per year and the prevalence rate is 10/100,000. Achalasia is quite difficult to establish 
because the symptoms might be insidious and therefore not many people come to seek medical attention until 
it deteriorates to final stage of the disease. There are several modalities that can be used as diagnostic tools 
such as manometry, barium esophagogram, esophagoduodenoscopy, esophageal CT-scan, until the recent one, 
high-resolution manometry that can classify achalasia into three different types. The treatment options are the 
pharmacologic intervention, endoscopic treatment, minimal invasive surgery, and radical surgery.
We reported a case of 20 year old female with achalasia who came with dysphagia symptom since 
three years before. The diagnosis was made by historytaking, physical examination and barium meal and 
esophagogastroduodenoscopy. The patient underwent pneumatic dilatation and since then the symptom was 
relieved. 
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ABSTRAK
Akalasia merupakan gangguan motorik esophagus dan sfingter esofagus yang jarang. Insiden berkisar 
1/100,000 pertahun dan angka prevalensinya 10/100,000. Gejala awal penyakit ini terselubung karena itu 
pasien baru berobat setelah stadium lanjut. Terdapat beberapa pilihan diagnosis seperti manometri, barium 
esofagogram, esofagoduodenoskopi, CT-scan esophagus dan akhir-akhir ini manometri resolusi tinggi dapat 
mengklasifikasikan akalasia menjadi berbagai tipe. Pilihan terapi akalasia antara lain intervensi farmakologi, 
terapi endoskopi, bedah minimal dan radikal.
Dilaporkan seorang perempuan usia 20 tahun dengan akalasia yang datang dengan gejala disfagia sejak 
tiga tahun sebelumnya. Diagnosis ditegakkan berdasarkan anamnesis, pemeriksaan fisik dan pemeriksaan 
barium meal, serta prosedur esofagogastroduodenoskopi. Setelah pasien menjalani tindakan dilatasi pneumatik 
kondisinya membaik tanpa keluhan lebih lanjut.
Kata kunci: akalasia, diagnostik, tatalaksana
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INTRODUCTION
Achalasia is a rare motor disorder of the esophagus 
and lower esophageal sphincter. Primary idiopathic 
achalasia is a quite rare disease, with an incidence of 
approximately 1/100,000 per year and a prevalence rate 
of 10/100,000.1 In Indonesia there were only 48 cases 
during 5 years period (1984-1988) that were documented 
by Division of Gastroenterology, Department of 
Internal Medicine, Cipto Mangunkusumo Hospital.2
Achalasia is quite difficult to establish because 
the symptoms might be insidious and therefore, not 
many people come to seek medical attention until 
it deteriorates to the final stage, which more drastic 
intervention such as esophagectomy. There are several 
modalities that can be used as diagnostic tools. There 
are esophageal manometry, barium esophagram, 
esophagoduodenoscopy, esophageal CT-scan, until 
the recent one, high-resolution manometry, which can 
classify achalasia into three different types (type I, II 
and III).3,4 It is important that we can diagnose achalasia 
in its early stage, so we can reduce the morbidity as 
well as cost-burden for the patient.
Those are several treatments available for achalasia 
nowadays. The options are the pharmacologic 
intervention, endoscopic treatment, minimal invasive 
surgery, and radical surgery. Each of the treatment has 
its own advantages, so as a clinician we must know 
what the best treatment of choice for each patient 
considering patient's characteristics included age, 
the severity of the illness, previous treatment, and 
socioeconomic status.
CASE ILLUSTRATION
A 20 year old female, came with a chief complaint 
of experiencing difficulties in swallowing since 
three years before admission. The patient was 
referred from Abdul Moeloek Hospital Lampung to 
undergo endoscopic pneumatic dilatation in Cipto 
Mangunkusumo Hospital Jakarta. Since five years 
before admission, patient had complained frequent 
runny nose, even though she did not have any common 
cold, mucus came out from her nose especially when 
lying on side. The patient consulted to the doctor and 
she was given some medications for sinusitis, including 
anti allergic and antibiotic but she did not feel any 
improvement. Since three years before admission, the 
patient experienced difficulties in swallowing solid 
and soft food. There was a discomfort sensation, dull 
pain inside the chest, and sensation like something was 
stuck inside her chest every meal. 
Since one year before admission, the patient began 
to experience difficulties in swallowing water as well 
as solid food, frequently experience dry cough, and 
felt like something crawling up her throat with like 
burn sensation. The patient coughed especially when 
lying on back. Later on that year, the patient coughed 
some blood out and was diagnosed as a tuberculosis 
(TB) case and was given TB medication for almost 2 
months and her doctor stop the medication because 
she did not have any improvement. Since ten months 
before admission, the patient had more difficulties in 
swallowing. She had to flush the food with water in 
order to swallow, frequently vomited after eating or 
drinking and began to lost her appetite. The patient 
only eat baby food and she lost about 40 kg in 2 years. 
One month before admission, the patient went to 
Abdul Moeloek Hospital and being told to undergo a 
radiologic examination and an endoscopic procedure. 
Later, the doctor told that she had some narrowing in her 
esophagus and being referred to Cipto Mangunkusumo 
Hospital for further treatment.
In the past history of illness, the patient never 
had any history of exposure to chemical material, no 
history of another cause for hospitalization, asthma nor 
allergic to food or medication and any lung disease. 
In family history, her mother has hypertension but no 
history of diabetes, malignancy, or similar illness. The 
patient did not smoke, no use of alcohol, drugs, and 
herbal medicine.
From physical examination, we found that patient 
looked moderately ill with vital sign blood pressure 
110/60 mmHg, pulse rate 84 times per minutes, 
respiration rate 18 times per minutes, body temperature 
36.7oC, normal color of conjunctiva and sclera and 
jugular venous pressure was 5-2 cmH2O. On chest 
examination, lung and heart were unremarkable. From 
abdominal examination, we found that the abdomen 
was flat, smooth, no tenderness on epigastrium. Liver 
and spleen were not palpable and bowel sound was 
normal, there was no shifting dullness on examination. 
On the extremities there was edema in both legs, felt 
warm and capillary refill time was below 3 seconds.
From laboratory examination, it was found that 
hemoglobin level was 12.8 g/dL, hematocrit 38%, 
platelets 234,000/mm3, leukocyte count 8,630/mm3 
with differential count basophil 0.2%, eosinophils 
1.7%, neuthrophils 73.5%, lymphocytes 10.9%, 
monocytes 15.7%, erythrocyte sedimentation rate 7 
mm/hour, ureum 27 mg/dL, creatinin 0.7 mg/dL, AST 
20 U/L, ALT 23 U/L, random blood glucose 98 g/dL, 
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natrium 140 mEq/L, kalium 3.55 mEq/L, chloride 
106mEq/L, coagulation result was normal.
From chest X-ray examination, we found that the 
cardio thoracic ratio was less than 50%, there were 
no infiltrations, and there were no sign of pleural 
effusions. From the electrocardiography there was no 
abnormality. The result of barium meal examination 
from the hospital before (Figure 1), there was a 
narrowing in the distal esophagus and the contrast could 
only pass through it slightly, there was also a 'beak 
shape’ appearance and the esophagoduodenoscopy 
(EGD) which was performed that the mucosa was 
normal, the vascularization was also normal, the lower 
esophageal sphincter (LES) was narrowing, but the 
scope can still went through LES. The impression from 
those examinations was achalasia.
Figure 1. Barium meal examination revealed a narrowing in 
the distal esophagus and the contrast could only slightly pass 
through and also a 'beak bird shape’ appearance
gave total parenteral nutrition at that time and we put 
a nasogastric tube in the middle of patient’s esophagus 
with flushing 3 times a day, to clear out any food left 
over. 
The patient then underwent the PD with good 
preparation and it succeeded. The dilatation was done 
by the balloon. Post dilatation,the stenosis region 
disappeared and there was only small amount of 
bleeding. The patient was scheduled for an evaluation 
1 month later after PD.
Figure 2. Esophageal appearance before the first dilatation 
showed narrowing of lower esophageal sphincter with reten-
tion of some food
From the history taking, physical examination and 
radiologic procedures the patient was diagnosed with 
achalasia and the patient was scheduled to undergo 
an endoscopic dilatation procedure using a pneumatic 
balloon. We tried to alleviate the symptoms of 
dysphagia, regurgitation and the burn sensation inside 
the chest by giving medications such as nifedipine 10 
mg three times a day before meal, omeprazole 20 mg 
twice a day, and sucralfate four times a day. The patient 
only felt slight improvement and still had a rough time 
in swallowing compact food. Therefore, we changed 
the diet into the combination between soft diet and 
milk, combining 1,900 kcal/day. The patient response 
was quite good. 
The first time the patient went for the pneumatic 
dilatation (PD) (Figure 2), it failed because the scope 
could not get a clear view because the patient still had 
many leftover of food inside her esophagus, proximal 
from the LES, and the patient was hard coughing, so the 
procedure was canceled and rescheduled. The patient 
then began to fast 2 days prior to the procedure, we 
The patient had the second dilatation in the 
following week after the first one. The second dilatation 
was also a success. She was still being hospitalized for 
a couple of days in order to observe if there was any 
complication of dilatation and to evaluate the response 
of dilatation. She could eat properly thereafter without 
experiencing any difficulties while eating or drinking, 
such as chest discomfort, pain or vomit. There were no 
more episodes of running nose or like burn sensation 
inside the chest.
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After several days of observation the patient was 
discharged and being told to have a routine check up 
to other gastroenterologist in her home town, at least 
one month after the procedure or sooner than that if 
she felt any more symptoms like she had experienced 
before. On the follow up, the patient still sometimes 
experiences chest discomfort while eating only solid 
food for the last 2 months. She can still eat like usual; 
there is no vomiting or weight loss.
DISCUSSION
There are several terms of achalasia: primary 
achalasia, secondary achalasia and pseudo-achalasia. 
Primary achalasia is a primary esophageal motor 
disorder of unknown etiology characterized 
manometrically by insufficient lower esophageal 
sphincter (LES) relaxation and loss of esophageal 
peristalsis, esophageal dilation, minimal LES opening 
with a “bird-beak” appearance, and poor esophageal 
emptying of barium.1 Secondary achalasia shares 
clinical features with primary achalasia, but there is 
always an identifiable cause. Worldwide, the most 
common cause of secondary achalasia is protozoal 
infection by Trypanosomacruzi, found in Central 
and South America.1 When achalasia is caused by 
infiltration of the lower esophageal sphincter, by 
malignancy, or by diseases such as amyloidosis, or 
as a result of a paraneoplastic syndrome, the term 
pseudoachalasia is used.1,2 This case will mainly focus 
in discussing primary type achalasia. 
Distal esophageal wall and LES are innervated by 
postganglionic neurons, consisting of excitatory and 
inhibitory neurons. The excitatory neurons release 
acetylcholine while the inhibitory neurons release 
nitric oxide (NO) and vasoactive intestinal polypeptide 
(VIP), resulting in esophageal and LES contractions 
and relaxations, respectively.
Achalasia results from the degeneration of neurons 
in esophageal wall. The NO and VIP releasing 
inhibitory neurons are the target cellsin idiopathic 
achalasia.6 Histologic examination shows the decrease 
amount of neurons (ganglion cell) in myenteric 
plexuses. The ganglion cells are surrounded by 
lymphocytes and less prominently by eosinophils. 
However this inflammatory degeneration relatively 
spares the cholinergic neurons (causing contraction 
of smooth muscle in LES) and preferentially affects 
nitric oxide producing inhibitory neurons (causing 
relaxation of smooth muscle).6,7 There is also one 
hypothesis about the role of interstitial cells of 
Cajal (ICC) that has been identified in LES (serving 
as pacemakers, as generators of a smooth muscle 
hyperpolarizing factor, asmechanicsensors, and as 
mediators of neurotransmission). In achalasia, there is 
also a reduction in number of ICC in LES.8
The hallmark of clinical presentation in achalasia 
is dysphagia for solid and liquids.1,2,3,4 Most achalasia 
patients are asymptomatic for years before seeking 
medical attention. The other symptoms are: 1) 
regurgitation, mostly in recumbent position, the 
patient awake from coughing and choking; 2) chest 
pain or discomfort located in the xiphoid area that 
may mimic angina by location and character, but not 
being aggravated by exercise or relieved by rest; 3) the 
sensation of heartburn because of gastroesophageal 
reflux disease (GERD) or the result of production 
of lactic acid from retained food or exogenous 
ingested acidic materials such as carbonated drinks; 
4) weight loss, the degree is usually mild (5 to 10 kg), 
but profound weight loss can be found; 5) various 
maneuvers, including lifting the neck, throwing the 
shoulder back, or drinking carbonated beverages to 
help empty the esophagus; 6) globus sensation, refer 
to lump-like sensation in the throat; 7) hiccups as a 
result from obstruction in distal esophagus.
In regard to patient's history of present illness, 
we could find many symptoms that could lead us to 
achalasia for our working diagnosis. First of all, the 
patient chief complaint was having difficulties in 
swallowing either food or liquid since three years before 
admission. It means that there was an abnormality in 
her digestive system, particularly in her esophagus. We 
have to suspect every patient that comes with dysphagia 
symptoms to have achalasia as their underlying disease. 
The other symptoms that can lead us to diagnosis of 
achalasia in this patient were regurgitation that she 
experienced while she was lying on her back, resulting 
in coughs. Then she also experienced chest discomfort, 
more like dull pain inside her chest whenever she ate. 
The sensation like something stuck inside her chest 
that patient had been complaining referred to globus 
sensation. There was also heartburn sensation in this 
patient that could be the result of GERD or the lactic acid 
produced by theretained food in her esophagus. She also 
had a maneuver that helped her swallowing food, which 
was drinking water immediately after swallowing some 
food, in order to flush them down passing through the 
LES. Weight loss was also an issue in this patientabout 
40 kg in 2 years. All those findings led us to achalasia, 
the next step was to establish thediagnosis and to classify 
which type of achalasia the patient had.
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The diagnosis of achalasia is based on the results 
of gastroscopy, manometry, and timed barium 
esophagography. When the diagnosis of achalasia is 
suspected, a barium esophagram with fluoroscopy is 
the single best diagnostic study. This test will reveal 
loss of primary peristalsis in the distal two-thirds 
of the esophagus with to-and-fro movement in the 
supine position. In the upright position, there will be 
poor emptying with retained food and saliva often 
producing a heterogeneous air-fluid level at the top of 
the barium column. Early in the disease, the esophagus 
may be minimally dilated, but more chronic disease is 
associated with sigmoid-like tortuosity and sometime 
massive dilation of the esophageal body. There is a 
smooth tapering of the lower esophagus leading to the 
closed LES, resembling a “bird’s beak”. The films are 
taken at 1, 2 and 5 minutes after the last swallow of 
barium; the purpose of 2 min film is to assess interim 
emptying.3,6,8 When findings of achalasia are present on 
barium studies, a narrowed distal esophageal segment 
longer than 3.5 cm with little or no proximal dilatation 
in a patient with recent onset of dysphagia should be 
considered highly suggestive of secondary achalasia, 
even in the absence of other suspicious radiographic 
findings.9
Manometry is the gold standard means for 
establishing the diagnosis of achalasia. We require 
esophageal aperistalsis to be present in order to 
diagnose achalasia. The LES displays high pressure 
at rest and fails to relax, or relaxes only partially with 
swallowing. Up to 40% of patients with achalasia have 
normal LES pressure (10–40 mm Hg).6 However, low 
pressure LES is not seen in untreated achalasia patients. 
Since the emergence of high resolution manometry 
(HRM) with pressure topography plotting, esophageal 
achalasia can be classified into three subtypes.3,10 In 
type I achalasia (classic achalasia), impaired LES 
relaxation but no significant pressurization within 
the esophageal body is observed. In type II achalasia 
(with compression), swallowing of water causes 
rapid panesophageal pressurization. This may exceed 
LES pressure, causing the esophagus to empty. Type 
III achalasia (spastic achalasia) is also associated 
with rapidly propagated pressurization; however, the 
pressurization is attributable to an abnormal lumen, 
obliterating contraction.3
All patients with suspected achalasia should 
undergo upper gastrointestinal endoscopy to exclude 
pseudoachalasia. At endoscopy, the esophageal 
body may look normal, or dilated, atonic and often 
tortuous. The mucosa looks normal, but sometimes 
it is thickened or friable with even superficial ulcers 
secondary to chronic stasis or candida esophagitis. 
The LES is closed even with insufflations of air, but 
the endoscope can easily pass this area with gentle 
pressure.3,4,6 If excess pressure is required, the presence 
of pseudoachalasia should be highly suspected, the 
gastroesophageal junction and cardia must be closely 
examined, and biopsies should be taken. Endoscopic 
ultrasonography may prove to be useful in patients 
with a non diagnostic endoscopy and a high degree 
of clinical suspicion for pseudoachalasia, but it is not 
recommended as a routine test.11
The suspicion of achalasia in this patient was 
established from the result of barium esophagram 
and endoscopic procedure. Although the main key 
test for establishing achalasia, manometry, had not 
been done, still we could be sure of that the main 
underlying disease for patient dysphagia was achalasia. 
It is said that barium esophagram is the single best 
diagnostic study because it can provide us with the 
specific appearance, especially if the disease is not 
in its early state. From barium esophagram we could 
find the "bird's beak" appearance, which meant that 
there was a smooth tapering of the lower esophagus 
leading to the closed LES. The endoscopic procedure 
in this patient was compulsory. Its purpose was not to 
reconfirm the diagnosis of achalasia that we had found 
from barium esophagram, but to distinguish between 
achalasia and pseudoachalasia. As many literature have 
stated, that all patients with suspected achalasia should 
undergo upper gastrointestinal endoscopy to exclude 
pseudoachalasia.1,6,11 From the first gastroscopy 
procedure in Abdoel Moeloek Hospital, we knew that 
there was a narrowing of LES but with the appliance 
of gentle pressure the scope can still pass through it. 
The diagnostic of achalasia is less likely to result from 
gastroscopy so there was no indication to do any biopsy 
or to have another examination such as CT scan or 
endoscopic ultrasonography, therefore the diagnosis of 
pseudoachalasia could be excluded. From gastroscopic 
findings, we could also know that there was no other 
condition that could worsen the condition of the patient 
such as ulcers or candida esophagitis secondary to 
chronic stasis.6
Currently, there was no cure for esophageal 
achalasia. The only available therapeutic options 
are to loosen the LES (focuses on relaxation or 
mechanical disruption of LES) and treat the symptoms. 
If achalasia is left untreated, a dilated esophagus with 
severe bolus transit impairment will develop, and that 
condition signals high risk for aspiration pneumonia 
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or perforation. Therefore, the goal in the management 
of achalasia is an early diagnosis and treatment before 
reaching this end-stage phase, when surgery becomes 
mandatory, but usually with a poor outcome.3,8
Pharmacologic agents used for achalasia are 
mostly smooth muscle relaxants that act by reducing 
LES pressure. Calcium channel blockers and long-
acting nitrates are the two most common medications 
used.1,5,8,12 Pharmacologic agents rarely yield 
satisfactory long-term alleviation of symptoms and 
are now only used in patients who are not candidates 
for pneumatic dilation or surgery. They also can be used 
during the planning stage for more effective therapy.6,8 
Calcium channel blockers inhibit cellular uptake of 
calcium, and because intracellular calcium is necessary 
for lower esophageal sphincter contraction, relaxation 
occurs. Calcium channel blockers have been evaluated 
in the long-term treatment of achalasia, but the use of 
these drugs often induces tolerance, which severely 
diminishes the effects over the time. Studies show that 
the time to maximum effect for sublingual nifedipine 
is 20 to 45 minutes; therefore, it is recommended 
nifedipine (10–30 mg) to be given sublingually 30 to 45 
minutes before meals and at bedtime. Nitrate therapy 
acts by counteracting the decrease in the inhibitory 
neurotransmitter, nitric oxide. This leads to a decrease 
in lower esophageal sphincter pressure. The effect of 
nitrate is more rapid than that of nifidipine, but has a 
shorter duration; thus, sublingually isosorbide dinitrate 
(ISDN) 2.5-5 mg or orally 10-20 mg is commonly 
administered only 10 to 15 minutes before meals.6,8,12 
The patient was scheduled to undergo a PD in 
Cipto Mangunkusumo Hospital, while she was waiting 
for it, she still suffered from the dysphagia and chest 
discomfort every meal time. There was absolutely 
an indication to give pharmacologic treatment for 
this patient, first that she was still having symptoms 
and second, that it was only for short period of time, 
while she was waiting for more definite treatment, so 
that we could avoid any unpleasant side effect such 
as headache, dizziness, and pedal edema.3  For that 
reason we chose to use nifedipine sublingually 10 mg 
before each meal. We also gave proton pump inhibitor, 
omeprazole 20 mg to be taken twice daily and also 
sucralfate as mucous protector to be taken four times 
daily to help alleviate the heartburn sensation.
Another common therapy for achalasia is endoscopic 
treatment; there were two available options currently, 
which were botulinum toxin (BT) injection or PD. 
Endoscopic treatment with BT injection at the terminal 
nerve endings of myoneural junctions prevents the 
release of acetylcholine from vesicles. This causes 
chemical denervation, which may last for several 
months. As a result of its wider safety range and 
fewer complications, local injection of BT into the 
LES muscle of patients with achalasia lowers LES 
tone, and the patient becomes asymptomatic. This 
treatment yields excellent immediate responses with 
success rates of  > 90%. However, the results last only 
6-9 motnhs on average in most patients, and only half 
of all the patients benefit for > 1 year.1,3,8 Botulinum 
toxin A 80–100 U is injected through a 5 mm needle 
into the LES, with aliquots of 20–25 U of the toxin 
injected into the four quadrants of the LES. The patients 
can go home after they recover from sedation and are 
allowed to eat soft foods later in the day. Symptomatic 
improvement occurs gradually and usually peaks 1–3 
days later, although this may be delayed even further 
in the occasional patient.6,8 Surgeons have reported that 
Heller myotomy could be more difficult in patients who 
undergo repeated botulinum toxin A injection due to 
increased adhesion of the muscular layer.13 Overall, 
BT is recommended to be most effective in elderly 
patients, in whom dilation or surgery represent a high 
risk, or in patients with comorbid illnesses who are not 
candidates for PD or myotomy.1,3,8,13
PD is the most effective non-surgical treatment 
option for patients with achalasia. It uses the air to 
dilate the esophageal lumen and disrupt the circular 
muscle fibers of the LES. Typically, pneumatic dilation 
is performed over a guide wire under fluoroscopic 
guidance. This allows for assessment of the progress 
of dilation as the narrowed “waist” of the lower 
esophageal sphincter disappears. However, in addition 
to radiation exposure, this requires bulky and expensive 
fluoroscopy equipment, which may be in high demand 
or not available for general use. Performing PD under 
direct endoscopic visualization is a good alternative to 
fluoroscopic guidance. After placement of the dilator 
over the guide wire, the endoscope is reinserted into 
the esophagus. The balloon placement and dilation 
effects are observed proximal to the balloon. The 
number of dilation sessions and the inflation time 
needed for a successful dilation vary and are operator 
dependent.3,8 In a prospective follow-up investigation 
study conducted by Eckardt et al, only 40% of the 
patients treated using a single PD procedure remained 
in remission at 5 years.14
This patient underwent PD for a definite treatment. 
This option was chosen because itwas the most 
effective therapy compare to the other therapies. It 
also uncommon to have any complication, the most 
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severe complication is perforation, and it only occurs 
in approximately 2% of cases.3 
The first attempt in this patient failed because 
there was so many food leftover inside the esophagus 
even though the patient had fasted 12 hour before 
the procedure. So the nasal gastric tube (NGT) was 
placed then, in the middle of patient's esophagus, 
proximal from the LES, and esophageal lavage was 
done every 2 hours until it was clear enough. The 
second attempt was a success, there was no more food 
leftover, the guide wire then being inserted to help the 
placement of the dilator, this procedure was done under 
fluoroscopy, to evaluate the precision of the balloon 
placement. After the balloon was put in the correct 
position, gastroesophageal junction fluoroscopically, 
then the balloon was dilated to obliterate the waist. 
From endoscopic evaluation after the dilatation we 
can see that the waist of achalasia was disappeared 
and there is no sign of any bleeding at that time. The 
patient then was observed for another couple of days 
to evaluate if there was any chest pain, bleeding, 
or difficulty in swallowing before being discharged 
home. The evaluation after the PD should include a 
barium swallow to see if there was any esophageal 
perforation, which was not being done in this patient. 
Timed barium esophagogram can be used as a better 
predictor of treatment success after PD. We have found 
that in almost 70% of the patients, the height of the 
barium column at 5 minute post-therapy correlates with 
symptom improvement (concordant group), while in 
others esophageal emptying was poor despite reports of 
excellent symptom relief (discordant group). Nearly all 
patients in discordant group failed the treatment within 
1 year after treatment, while 77% of the concordant 
groups were still in symptom remission after 6 years 
of follow-up. Therefore, it is suggested that the timed 
barium esophagogram not only assesses treatment 
shortly after therapy, it can also predict the poor 
response to the treatment if the patient has retained 
barium postpneumatic dilation.15
From the follow up one month after, the patient had 
no difficulty in swallowing or had any chest discomfort 
like she had used to have before. Although from the 
follow up 5 months after, the patient began to feel 
slight chest discomfort again after eating, but this time 
there was no sign of regurgitation, heartburn sensation, 
or any extra effort to help the patient in swallowing 
food. It is generally accepted that the predictors of 
risk factors for relapse after PD include young age 
(< 40 - 45 years), male, single dilation with a 3.0 cm 
balloon, post-treatment LES pressure > 10-15 mmHg, 
poor esophageal emptying after timed barium swallow, 
and type I and type III achalasia pattern on HRM.3 In 
this patient the risk factors are young age (20 years 
old) and single dilation.
The patient may need for another dilation session 
using a wider diameter of the balloon (3.5 cm and 4 
cm). If there wasstill any symptom then the patient 
should undergo a laparoscopic myotomy (Heller 
myotomy). This technique is associated with the 
greater decrease in dysphagia, a shorter hospital stay, 
lower risk of postoperative gastroesophageal reflux, 
and low complication rates. An entire flux procedure 
can further reduce postoperative heartburn rates by 
80%, as well as the risk of esophagitis and peptic 
stricture.8,13 If there is still no improvement and the 
patient is already in the late stage of the disease, with 
mega esophagus or there is any complication from the 
latter myotomy such as adenocarcinoma in Barrett’s 
esophagus then drastic measure need to be done, which 
is esophagectomy. 
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